Sparton Corporation  

(Public, NYSE:SPA)   Watch this stock  
Find more results for SPA
24.01
+0.11 (0.46%)
Real-time:   9:54AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 23.95 - 24.01
52 week 19.60 - 30.34
Open 23.95
Vol / Avg. 3,094.00/37,076.00
Mkt cap 237.95M
P/E 27.17
Div/yield     -
EPS 0.88
Shares 9.91M
Beta 1.75
Inst. own 63%
Jun 4, 2015
Sparton Corp at Three Part Advisors East Coast IDEAS Investor Conference
May 14, 2015
Sparton Corp at Barrington Research Spring Investment Conference
May 6, 2015
Q3 2015 Sparton Corp Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 4.44% 3.86%
Operating margin 5.25% 5.92%
EBITD margin - 8.45%
Return on average assets 7.33% 7.12%
Return on average equity 14.89% 12.60%
Employees 1,385 -
CDP Score - -

Address

Suite 2050, 425 N. Martingale Road
SCHAUMBURG, IL 60173
United States - Map
+1-847-7625800 (Phone)
+1-517-7871822 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Sparton Corporation and subsidiaries (Sparton) is a provider of electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, and field service. The Company serves the medical, military and aerospace and industrial and instrumentation markets through two reportable business segments such as Manufacturing & Design Services (MDS) and Engineered Components & Products (ECP). The MDS segment represents its contract manufacturing and design services where the customer owns the related intellectual property. The ECP segment represents its manufacturing and design services where the Company owns the related intellectual property. The Company's products and services include products for original equipment manufacturers (OEM) and technology (ET) customers that are microprocessor-based systems that include transducers, printed circuit boards and assemblies, and electromechanical components.

Officers and directors

James R. Swartwout Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Cary B. Wood President, Chief Executive Officer, Interim Chief Financial Officer, Director
Age: 47
Bio & Compensation  - Reuters
Joseph Thomas Schneider Senior Vice President, Sales and Marketing
Bio & Compensation  - Reuters
Michael W. Osborne Senior Vice President - Corporate Development
Age: 43
Bio & Compensation  - Reuters
Steven M. Korwin Senior Vice President - Quality, Engineering and Information Systems
Age: 51
Bio & Compensation  - Reuters
Gordon B. Madlock Senior Vice President - Operations
Age: 56
Bio & Compensation  - Reuters
Lawrence R. Brand Vice President - Human Resources
Age: 47
Bio & Compensation  - Reuters
Mike Gaul Group Vice President - Medical Manufacturing
Age: 60
Bio & Compensation  - Reuters
James M. Lackemacher Group Vice President - DSS Engineered Products
Age: 52
Bio & Compensation  - Reuters
Christopher Ratliff Vice President - Information Technology
Age: 49
Bio & Compensation  - Reuters